Stanford's VirtualBiotech in Science: tens of thousands of agents run a pharma firm
Stanford's James Zou team published VirtualBiotech in Science: a virtual CSO leading 8 'AI scientists' that operate like a small pharma company using over 37,000 agents. Follow-up analyses unpack the system's engineering and six key design decisions behind an auditable AI drug firm.
2026-09-22 ~ 2026-09-22 · 3 related posts
- Episode 1: Stanford's 37,000-Agent Virtual Biotech Discovers Potential Lung Cancer Drug(2026-09-20, 5 posts)
- Episode 2: Stanford's VirtualBiotech in Science: tens of thousands of agents run a pharma firm(2026-09-22, 3 posts)
- Stanford's VirtualBiotech puts tens of thousands of AI scientist agents in Science, NYT reports — StanfordAILab · 2026-09-22
- 37,000-agent virtual drug company: the engineering behind Virtual Biotech — bravo_abad · 2026-09-22
- Virtual Biotech teardown: 6 design decisions behind Science's 37,000-agent drug company — bravo_abad · 2026-09-22